Effectiveness of low‐dose pasireotide in a patient with Cushing's disease: antiproliferative effect and predictivity of a short pasireotide suppression test

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|3|8|718-722

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.8, 2015-08, pp. : 718-722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pasireotide (SOM230) as a Potential Treatment for Endocrine and Non- Endocrine Tumors

By  

Current Drug Therapy, Vol. 5, Iss. 4, 2010-11 ,pp. : 301-311

Bentham Science Publishers

Access to resources Recommend Favorite

Low‐dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects

By  

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 635-637

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides

By Papadavid Evangelia   Antoniou Christina  

American Journal of Clinical Dermatology, Vol. 9, Iss. 3, 2008-01 ,pp. : 169-173

Adis International

Access to resources Recommend Favorite

High‐flux hemodialysis after administering high‐dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function

By  

Clinical Case Reports, Vol. 3, Iss. 11, 2015-11 ,pp. : 932-936

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study

By Sekuri C.   Bayturan O.   Gocer H.   Tavli T.   Tezcan U.K.  

Current Therapeutic Research, Vol. 64, Iss. 9, 2003-11 ,pp. : 715-724

Elsevier

Access to resources Recommend Favorite